Author Archive for: maureen-hensley-quinn
About Maureen Hensley-Quinn
Maureen-Hensley Quinn, Senior Program Director, at the National Academy for State Health Policy (NASHP) leads the Emerging Policy Issues team that focuses on states’ efforts to finance, provide and improve coverage and care through public and publicly subsidized health programs. Maureen participates in and manages multiple projects that focus on health coverage for children, streamlining eligibility, enrollment and renewal policies and procedures affecting multiple health coverage programs, as well as supporting states’ efforts to implement federal and state health care reforms. In addition to research and analysis of federal and state laws and regulations, Maureen has designed and implemented technical assistance for states that includes state-to-state peer learning activities. Maureen directs NASHP’s children’s coverage work that supports the nation’s Children’s Health Insurance Program (CHIP) directors to continually improve coverage and care for low- to moderate-income children and pregnant women.
Prior to joining the staff of NASHP in 2007, Maureen was the Medical Specialist at the Community Transportation Association of America (CTAA). At CTAA, Maureen focused on the public’s access to health care through analysis of public health coverage (Medicaid in particular) and state and federal transportation policies. Prior to working at CTAA, Maureen was a Mediator/Legal Analyst within the Insurance Division of the Massachusetts State Attorney General’s Office. In this role she provided education to consumers and advocated on their behalf for improved treatment and coverage, particularly in health care (both public and private). Maureen received a Bachelor’s degree in Political Science from Merrimack College in Massachusetts and earned a Master’s degree in Public Affairs from the John W. McCormack School of Public Policy at the University of Massachusetts in Boston.
Entries by Maureen Hensley-Quinn
With support from Arnold Ventures, the National Academy for State Health Policy (NASHP) is expanding its capacity to help states lower the trajectory of their health care spending through its new Center for State Health Care System Costs. Modeled on the work of its Prescription Drug Pricing Center, this new center will address health system […]
US Census Bureau data released this past week revealed 8.5 percent (27.5 million people) did not have health coverage at any point during 2018 – an increase from 7.9 percent (25.6 million people) in 2017. The latest census data also affirmed fears raised after reports of declining child enrollment in Medicaid and the Children’s Health […]
The Department of Homeland Security (DHS) recently finalized a rule that significantly changes immigration policies related to “public charge” determinations. Under long-established US immigration policies, individuals who are deemed likely to become a “public charge” and require extensive government support can be denied an adjustment of their immigration status (e.g., issued a green card) or […]
In 2019, states built on the momentum that had been gaining in recent years and passed targeted legislation to address the role harmful pharmacy benefit manager (PBM) business practices play in escalating prescription drug prices. The laws supporting these approaches, described below, give states enforcement mechanisms to ensure that the discounts that PBMs recoup are […]
Last week, Maine Gov. Janet Mills signed into law a comprehensive package of prescription drug cost control legislation that addresses pharmaceutical prices throughout the supply chain. The four new laws include: Stricter requirements on pharmacy benefit managers (PBMs); Updates to its drug transparency program to require more prescriptive data collection and enforcement mechanisms; Establishment of […]
With hepatitis C infections on the rise and curative, but expensive, prescription drugs now available, state leaders across the country are compelled to address this public health crisis, and Louisiana and Washington are developing innovative drug-purchasing strategies within their efforts. At the same time, the Patient-Centered Outcomes Research Institute (PCORI) is investing in patient-focused studies […]